273
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Flowable Collagen Hemostat Evaluated in Preclinical Models of Liver Injury and Spinal Cord Exposure

, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 123-132 | Received 29 Mar 2023, Accepted 29 May 2023, Published online: 05 Jun 2023

References

  • Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11:135. doi:10.1186/1472-6963-11-135
  • Schreiber MA, Neveleff DJ. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J. 2011;94(5):S1–S20. doi:10.1016/j.aorn.2011.09.018
  • Zimmerman LH. Causes and consequences of critical bleeding and mechanisms of blood coagulation. Pharmacotherapy. 2007;27(9 Pt 2):45S–56S. doi:10.1592/phco.27.9part2.45S
  • Overbey DM, Jones EL, Robinson TN. How hemostatic agents interact with the coagulation cascade. AORN J. 2014;100(2):148–159. doi:10.1016/j.aorn.2013.12.012
  • Burks S, Spotnitz W. Safety and usability of hemostats, sealants, and adhesives. AORN J. 2014;100(2):160–176. doi:10.1016/j.aorn.2014.01.026
  • Ozawa S. Patient blood management: use of topical hemostatic and sealant agents. AORN J. 2013;98(5):461–478. doi:10.1016/j.aorn.2013.08.014
  • Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36(9):2667–2674. doi:10.1097/CCM.0b013e3181844677
  • DeAndra JA, Elefteriades JA, Hasaniya NW, Lattouf OM, Lazzara RR. Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery. J Card Surg. 2009;24(3):325–333. doi:10.1111/j.1540-8191.2009.00809.x
  • Shander A, Kaplan LJ, Harris MT, et al. Topical hemostatic therapy in surgery: bridging the knowledge and practice gap. J Am Coll Surg. 2014;219(3):570–579 e574. doi:10.1016/j.jamcollsurg.2014.03.061
  • Schonauer C, Mastantuoni C, Somma T, de Falco R, Cappabianca P, Tessitore E. Topical hemostatic agents in neurosurgery, a comprehensive review: 15 years update. Neurosurg Rev. 2022;45(2):1217–1232. doi:10.1007/s10143-021-01684-1
  • Roberto Giammalva G, Brunasso L, Costanzo R, et al. The role of hemostatic devices in neurosurgery. A systematic review. J Clin Neurosci. 2021;89:151–157. doi:10.1016/j.jocn.2021.05.016
  • Cziperle DJ. Avitene microfibrillar collagen hemostat for adjunctive hemostasis in surgical procedures: a systematic literature review. Med Devices. 2021;14:155–163. doi:10.2147/MDER.S298207
  • Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg. 2010;251(2):217–228. doi:10.1097/SLA.0b013e3181c3bcca
  • Lewis KM, Li Q, Jones DS, et al. Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents. Surgery. 2017;161(3):771–781. doi:10.1016/j.surg.2016.09.022
  • Ereth M, Sibonga J, Oliver W, Nuttall G, Henderson J, Dekutoski M. Microporous polysaccharide hemospheres do not inhibit bone healing compared to bone wax or microfibrillar collagen. Orthopedics. 2008;31(3):222.
  • Guo D, Li D, Li J, et al. Topical application of the hematostatic agent Surgiflo(R) could attenuate brain injury in experimental TBI mice. Neurol Res. 2017;39(9):830–836. doi:10.1080/01616412.2017.1330815
  • Gazzeri R, Galarza M, Alfier A. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures. Surg Technol Int. 2012;22:49–54.
  • Landi A, Gregori F, Marotta N, Delfini R. Efficacy, security, and manageability of gelified hemostatic matrix in bleeding control during thoracic and lumbar spine surgery: floSeal versus surgiflo. J Neurol Surg a Cent Eur Neurosurg. 2016;77(2):139–143. doi:10.1055/s-0035-1558413
  • Chen Z, Yao J, Zhao J, Wang S. Injectable wound dressing based on carboxymethyl chitosan triple-network hydrogel for effective wound antibacterial and hemostasis. Int J Biol Macromol. 2023;225:1235–1245. doi:10.1016/j.ijbiomac.2022.11.184
  • Wang T, Yi W, Zhang Y, et al. Sodium alginate hydrogel containing platelet-rich plasma for wound healing. Colloids Surf B Biointerfaces. 2023;222:113096. doi:10.1016/j.colsurfb.2022.113096
  • Xu X, Zeng Y, Chen Z, et al. Chitosan-based multifunctional hydrogel for sequential wound inflammation elimination, infection inhibition, and wound healing. Int J Biol Macromol. 2023;235:123847. doi:10.1016/j.ijbiomac.2023.123847